VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Advanced solid tumor malignancy (during expansion  │ Advanced solid tumor malignancy (during expansion  │     100 │
│ at the maximum tolerated dose, entry will be       │ at the maximum tolerated dose, entry will be       │         │
│ limited to patients wtih adenocarcinoma of the     │ limited to patients wtih adenocarcinoma of the     │         │
│ colon or rectum)                                   │ colon or rectum)                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Eastern Cooperative Oncology Group (ECOG) 0 or 1   │ Eastern Cooperative Oncology Group (ECOG) 0 or 1   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Prior treatment with more than 6 cycles of         │ Prior treatment with more than 6 cycles of         │     100 │
│ traditional alkylating agent-based chemotherapy    │ traditional alkylating agent-based chemotherapy    │         │
│ regimens                                           │ regimens                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Prior treatment with more than 2 cycles of         │ Prior treatment with more than 2 cycles of         │     100 │
│ carboplating-based chemotherapy regimens           │ carboplating-based chemotherapy regimens           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ For colorectal cancer patients in the expanded     │ For colorectal cancer patients in the expanded     │     100 │
│ cohorts, prior treatment with more than 2 systemic │ cohorts, prior treatment with more than 2 systemic │         │
│ chemotherapy regimens in the metastatic setting    │ chemotherapy regimens in the metastatic setting    │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                    │   Score │
╞═══════════════════════════════════╪══════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Eastern Cooperative Oncology Group (ECOG) 0 or 1 │      35 │
╘═══════════════════════════════════╧══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 89.16666666666667
OverAll Ratio: 93.08333333333334
